Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E5555 for non-ST-segment elevation acute coronary syndrome
ACTRN12607000544471Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of atopaxar in acute coronary syndrome (ACS) (4 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Major bleeding events. Started Dec 2007; status: completed.
02
Drugs
atopaxar
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ACTRN12607000544471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000544471.